Michael G. Crooks

5.1k total citations · 3 hit papers
81 papers, 1.5k citations indexed

About

Michael G. Crooks is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Neurology. According to data from OpenAlex, Michael G. Crooks has authored 81 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 29 papers in Physiology and 12 papers in Neurology. Recurrent topics in Michael G. Crooks's work include Respiratory and Cough-Related Research (31 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers) and Asthma and respiratory diseases (18 papers). Michael G. Crooks is often cited by papers focused on Respiratory and Cough-Related Research (31 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers) and Asthma and respiratory diseases (18 papers). Michael G. Crooks collaborates with scholars based in United Kingdom, Netherlands and United States. Michael G. Crooks's co-authors include Alyn H. Morice, Dominic L. Sykes, Simon P. Hart, Luke Holdsworth, Pumali Gunasekera, Nadine Jawad, Amitava Banerjee, Melissa Heightman, Emily Attree and Mark Gabbay and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Michael G. Crooks

74 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It?

2021 361 citations Dominic L. Sykes, Luke Holdsworth et al. Lung profile →
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study

2021 345 citations Andrea Dennis, Daniel J. Cuthbertson et al. profile →
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study

2023 59 citations Andrea Dennis, Daniel J. Cuthbertson et al. Journal of the Royal Society of Medicine profile →

Peers

Countries citing papers authored by Michael G. Crooks

Since Specialization

Citations

This map shows the geographic impact of Michael G. Crooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Crooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Crooks more than expected).

Fields of papers citing papers by Michael G. Crooks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Crooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Crooks. The network helps show where Michael G. Crooks may publish in the future.

Co-authorship network of co-authors of Michael G. Crooks

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Crooks. A scholar is included among the top collaborators of Michael G. Crooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Crooks. Michael G. Crooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Prompt Initiation of Budesonide/Glycopyrrolate/Formoterol Fumarate (BGF) After an Exacerbation is Associated With Reduced Exacerbation and Cardiopulmonary Risk in Patients With COPD: The MITOS EROS+CP (US) Study	American Journal of Respiratory and Critical Care Medicine	Michael Pollack, Hayley D. Germack et al.	0
2	Nighttime Cough Characteristics in Chronic Obstructive Pulmonary Disease Patients	Sensors	Albertus C. den Brinker, Susannah Thackray-Nocera et al.	1
3	Effects of Azithromycin on Blood Inflammatory Gene Expression and Cytokine Production in Sarcoidosis	Lung	Simon Fraser, Susannah Thackray-Nocera et al.	1
4	Prevalence, risk factors and characterisation of individuals with long COVID using Electronic Health Records in over 1.5 million COVID cases in England	Journal of Infection	Han‐I Wang, Tim Doran et al.	8
5	A simple and effective evidence-based approach to asthma management: ICS-formoterol reliever therapy	British Journal of General Practice	Mark L Levy, Richard Beasley et al.	1
6	The Effect of Long-Term Azithromycin on Objective and Subjective Cough in Chronic Respiratory Disease: A Systematic Review and Meta-analysis of Randomised Controlled Trials and Noncomparative Studies	Lung	Dominic L. Sykes, Simon P. Hart et al.	2
7	Exploring patients’ and carers’ experiences, understandings and expectations of COPD exacerbations:an interview study	BJGP Open	Anne Hutchinson, Richard Russell et al.	1
8	Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study breakdown →	Journal of the Royal Society of Medicine	Andrea Dennis, Daniel J. Cuthbertson et al.	59
9	Improving asthma care through implementation of the SENTINEL programme: findings from the pilot site	ERJ Open Research	Michael G. Crooks, Judith Cohen et al.	12
10	Telerehabilitation for patients who have been hospitalised with covid-19: a qualitative study	Disability and Rehabilitation	Clare Killingback, Mark A. Thompson et al.	7
11	STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: A structured protocol	PLoS ONE	Denise Forshaw, Emma Wall et al.	20
12	Towards codesign in respiratory care: development of an implementation-ready intervention to improve guideline-adherent adult asthma care across primary and secondary care settings (The SENTINEL Project)	BMJ Open Respiratory Research	Mark Pearson, Michael G. Crooks et al.	8
13	Environmental Sustainability in Respiratory Care: An Overview of the healthCARe-Based envirONmental Cost of Treatment (CARBON) Programme	Advances in Therapy	Alex Wilkinson, Ekaterina Maslova et al.	14
14	Outcomes and characteristics of COVID-19 patients treated with continuous positive airway pressure/high-flow nasal oxygen outside the intensive care setting	ERJ Open Research	Dominic L. Sykes, Michael G. Crooks et al.	8
15	Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective	ERJ Open Research	Dominic L. Sykes, Shoaib Faruqi et al.	31
16	Suppression ofF_ENOwith observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?	ERJ Open Research	Shoaib Faruqi, Joanne Thompson et al.	8
17	Is cough important in acute exacerbations of COPD?	Respiratory Physiology & Neurobiology	Michael G. Crooks, Alyn H. Morice et al.	10
18	Long term ambient cough count compared to symptom data	European Respiratory Journal	Albertus C. den Brinker, Michael G. Crooks et al.	1
19	COPD telemonitoring: Analysis of hospital admissions	European Respiratory Journal	Michael G. Crooks, Christine Alexander et al.	1
20	Daily remote cough monitoring in COPD	European Respiratory Journal	Michael G. Crooks, Albertus C. den Brinker et al.	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact